Synonyms: BSI-201 | SAR240550
Compound class:
Synthetic organic
|
|
References |
1. Liu X, Shi Y, Maag DX, Palma JP, Patterson MJ, Ellis PA, Surber BW, Ready DB, Soni NB, Ladror US et al.. (2012)
Iniparib nonselectively modifies cysteine-containing proteins in tumor cells and is not a bona fide PARP inhibitor. Clin Cancer Res, 18 (2): 510-23. [PMID:22128301] |
2. Mendeleyev J, Kirsten E, Hakam A, Buki KG, Kun E. (1995)
Potential chemotherapeutic activity of 4-iodo-3-nitrobenzamide. Metabolic reduction to the 3-nitroso derivative and induction of cell death in tumor cells in culture. Biochem Pharmacol, 50 (5): 705-14. [PMID:7669074] |
3. O'Shaughnessy J, Osborne C, Pippen JE, Yoffe M, Patt D, Rocha C, Koo IC, Sherman BM, Bradley C. (2011)
Iniparib plus chemotherapy in metastatic triple-negative breast cancer. N Engl J Med, 364 (3): 205-14. [PMID:21208101] |
4. Patel AG, De Lorenzo SB, Flatten KS, Poirier GG, Kaufmann SH. (2012)
Failure of iniparib to inhibit poly(ADP-Ribose) polymerase in vitro. Clin Cancer Res, 18 (6): 1655-62. [PMID:22291137] |